neonatal lupus

Neonatal lupus can develop from transplacental passage of maternal anti-SSA (Ro) and anti-SSB (La) antibodies. The presence of these antibodies in the mother is associated with a small (<2%) but significant risk of congenital complete heart block. Hepatic, hematologic, and dermatologic complications are also possible. Hydroxychloroquine does not have significant fetal toxicity, and discontinuation during pregnancy is associated with an increase in maternal SLE activity (Choice B). In contrast, cyclophosphamide, methotrexate, leflunomide, and mycophenolate are contraindicated in pregnancy.

Backlinks